Are electronic signatures acceptable for FDA records?

Yes. Electronic signatures and records are acceptable when they meet applicable controls under 21 CFR Part 11 and federal e-signature law such as the ESIGN Act (15 U.S.C. ch. 96) or relevant state UETA provisions.

What makes an e-signature Part 11 compliant?

Part 11 compliance requires controls such as validated systems, audit trails, unique user IDs, and procedures for signature manifestations and record retention to ensure trustworthiness and reliability.

Who can sign the compliance document?

Authorized individuals with role-based authority should sign; include printed name, job title, and an attestation. For regulatory attestations, senior QA or regulatory officers are commonly designated signatories.

How long must I retain the record?

Retention depends on record type: follow federal minima (e.g., IRS 3 years, HIPAA 6 years) and extend for industry-specific requirements; document retention policy should be explicit.

What authentication strength is recommended?

Use at least two-factor authentication or verified identity proofing for high-risk approvals. Stronger authentication supports signer attribution and reduces the risk of regulatory findings.

How do I correct an error after signing?

Do not alter the signed record. Instead, create a controlled amendment or revision with cross-reference to the original, capture approvals, and preserve both versions and audit trails.

Electronic Signature
Templates
Miscellaneous
FDA Compliance Document

FDA Compliance Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

FDA Compliance Document

This FDA Compliance Document (the Agreement) is entered into as of Effective Date: by and between:

Company Name: Company Address: Service Provider Name: Service Provider Address:

WHEREAS

WHEREAS, Company operates or controls a facility located at that manufactures, labels, or supplies products subject to regulation by the Food and Drug Administration (FDA); and

WHEREAS, Service Provider is retained to perform services described below necessary to establish, maintain, or verify compliance with applicable FDA requirements, subject to the terms and conditions set forth in this Agreement; and

WHEREAS, the parties desire to set forth responsibilities, reporting obligations, recordkeeping, and audit rights to ensure regulatory compliance and to allocate risk associated with noncompliance.

Scope of Work

Service Provider shall perform the compliance services described below. Services may include inspection support, document review, validation assistance, training, regulatory submission support, corrective and preventive action (CAPA) assistance, and other tasks necessary to support Company’s FDA compliance program. Specific deliverables, timelines, and performance standards are described in the Scope of Work field.

Detailed Scope of Work and Deliverables:

Payment Terms

In consideration for the services performed by Service Provider, Company shall pay Service Provider in accordance with the following terms.

Total Contract Amount: Payment Schedule and Milestones: Late Payment Fee / Interest:

Term and Termination

This Agreement shall commence on Start Date: and shall continue until End Date: unless earlier terminated in accordance with this section.

Either party may terminate this Agreement for convenience upon written notice to the other party at least days prior to the effective termination date. Either party may terminate immediately for material breach, including but not limited to failures to comply with FDA obligations or falsification of regulatory records.

Regulatory Compliance and Certifications

Service Provider represents and warrants that, as of the Effective Date, it has the training, qualifications, and documented procedures necessary to perform the Scope of Work and that it will perform services in a manner consistent with applicable FDA requirements and recognized quality systems. Company represents that it will maintain all registrations, listings, and records required by applicable law.

Certifications (select all that apply):

Service Provider complies with current Good Manufacturing Practices
Service Provider maintains required regulatory registrations and listings
Service Provider will maintain records and make them available for inspection as required

Recordkeeping, Reporting and Adverse Events

Service Provider shall maintain complete and accurate records of all work performed under this Agreement for a minimum of years, unless a longer retention period is required by law.

Service Provider shall report any adverse event, product complaint, or other safety concern related to Company’s products to Company within calendar days of discovery. Company shall be responsible for determining regulatory reporting obligations and for making any filings required by law.

Audit Rights and Inspections

Company and authorized regulatory authorities shall have the right to audit Service Provider’s relevant records and facilities to verify compliance with this Agreement and applicable regulatory requirements. Service Provider agrees to provide timely access and reasonable cooperation in connection with such audits and inspections.

Audit Rights Acknowledged:

Acknowledged

Corrective and Preventive Action (CAPA)

If nonconformities, deviations, or potential regulatory findings are identified, Service Provider shall propose corrective and preventive actions. Company shall review and approve CAPA plans; Service Provider shall implement approved CAPA and provide documentation demonstrating effectiveness.

CAPA Process and Reporting Requirements:

Confidentiality

Each party shall treat all non-public information disclosed under this Agreement as Confidential Information. Confidential Information shall not be disclosed to third parties except as required by law, including regulatory authorities, and then only after prior notice to the disclosing party where permitted.

The obligations of confidentiality shall survive termination of this Agreement for a period of years.

Indemnification

Each party shall indemnify, defend and hold harmless the other party from and against any losses, liabilities, fines, penalties, and third-party claims arising from that indemnifying party’s breach of this Agreement, negligent acts or omissions, willful misconduct, or failure to comply with applicable regulatory requirements. Indemnification obligations include costs of defense, settlement, and any regulatory fines attributable to the indemnifying party’s actions.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of laws principles.

Entire Agreement

This Agreement, including any attachments or exhibits listed below, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, and communications, whether written or oral.

Attachments / Exhibits (describe):

Authorized Contact

Name: Phone: Email:

Company - Printed Name:

By:

Date:

Service Provider - Printed Name:

By:

Date:

What the FDA Compliance Document Is and When It’s Used

An FDA Compliance Document is a structured record used to demonstrate that a product, process, or activity meets applicable Food and Drug Administration requirements. It typically collects evidence such as standard operating procedures, validation reports, change-control logs, training records, and signed attestations. For electronic records that support submissions or inspections, the document should align with 21 CFR Part 11 for electronic records and signatures and with federal e-signature frameworks (ESIGN/UETA) for legal enforceability. Organizations use these documents for internal audits, regulatory submissions, inspections, and supplier oversight.

Why an FDA Compliance Document Matters for Regulatory Readiness

A complete, accurate FDA Compliance Document reduces regulatory risk by preserving audit evidence, proving procedural controls, and demonstrating traceability. Properly maintained records help during inspections and reduce the likelihood of warning letters or enforcement actions.

Typical Users and Stakeholders

Teams and roles commonly responsible for preparing FDA Compliance Documents include quality assurance, regulatory affairs, manufacturing, clinical operations, and legal.

Quality Assurance and Regulatory Affairs teams managing SOPs, validations, and inspection responses across product lines.
Manufacturing and Operations staff documenting batch records, deviations, corrective actions, and equipment qualifications.
Legal and Compliance reviewers verifying attestations, contracts, and supplier commitments before final sign-off.

Multiple parties review and sign the record before it is filed or retained, and distribution typically follows a role-based workflow with QA and regulatory owners.

Core Elements to Include in a Professional FDA Compliance Document

A professional document groups metadata, evidence, approvals, and an immutable audit trail. Each component supports traceability, reproducibility, and regulatory review.

Document Header

Title, version, document owner, effective date, and revision history so reviewers can verify currency and provenance.

Scope & Purpose

Concise description of applicability and objectives to limit ambiguity during inspections and to guide internal reviewers and auditors.

Supporting Evidence

Attachments such as validation reports, certificates, test data, and batch records that substantiate claims in the primary document.

Signatures & Timestamps

Signed approvals with timestamps and signer attribution to meet electronic signature traceability requirements under 21 CFR Part 11.

Audit Trail

Immutable log of modifications, user actions, and export events that demonstrates record integrity and change control.

Change Control Notes

Linked history of revisions, approvals, and rationale so reviewers can assess why changes were made and who authorized them.

Key Security and Compliance Attributes to Verify

Encryption: TLS 1.2/1.3 in transit, AES-256 at rest

21 CFR Part 11: Controls for audits and signatures

HIPAA BAA: BAA required for PHI handling

SOC 2 Type II: Independent controls attestation

ISO 27001: Information security management

WCAG Accessibility: Level AA compliant

Step-by-Step: Preparing and Approving an FDA Compliance Document

Follow a consistent sequence: prepare, validate evidence, route for review, collect signatures, and store with retention metadata.

01

Draft: Compile content and attach supporting evidence files.
02

Internal Review: QA and subject matter experts review for accuracy.
03

Regulatory Approval: Regulatory affairs confirms compliance language and citations.
04

Sign and Archive: Capture signatures, timestamp, and archive with retention metadata.

How to Configure an Electronic Workflow for This Document

Set up role-based routing, authentication strength, and retention rules to ensure the record meets regulatory expectations and auditability.

Field	Configuration
Authentication	Enable email + optional SMS or stronger MFA for high-risk signers
Routing Order	Define sequential approvers: author → QA → regulatory → legal
Retention Tag	Apply retention policy metadata per record type
Audit Trail	Capture IP, timestamp, and action logs for every signer

Typical Digital Submission Flow

A reliable digital process reduces friction while preserving evidence required for regulatory review and inspection readiness.

Upload Document: Attach primary file and supporting evidence.
Place Fields: Add signature, date, and checkbox fields.
Assign Signers: Set signer roles and routing order.
Complete & Archive: Capture audit trail and store in secure archive.

Technical and Integration Considerations

Verify the platform supports required file formats, audit logging, and integrations before you begin.

File Formats: PDF, DOCX, XLSX supported
Integrations: Salesforce, NetSuite, Google Workspace
Export Options: Signed PDF with audit trail

Common Timing Considerations and Internal Deadlines

Set and document internal deadlines so reviews and approvals complete before any external reporting or submission deadlines.

Draft Completion Target:

Allow 5–10 business days for initial drafting and evidence collection.

QA Review Window:

Allocate 3–7 business days for QA technical review and corrections.

Regulatory Sign-off:

Plan 5 business days for regulatory affairs approval on substantive changes.

Submission Lead Time:

Allow extra time for formatting and Part 11 checks before filing.

Audit Readiness:

Retain final record and evidence immediately after signature for inspection availability.

Common Pitfalls to Avoid When Preparing the Document

Using inconsistent version numbering or missing revision history, which creates uncertainty during inspections and can delay approvals.
Failing to capture a complete audit trail (IP, timestamps, user actions), undermining the record’s credibility under 21 CFR Part 11.
Applying weak authentication for critical signatures; insufficient identity proofing increases regulatory risk and potential noncompliance findings.
Omitting supporting raw data, test reports, or calibration certificates, which can prompt FDA requests or inspection deficiencies.

Consequences of an Incorrect or Incomplete FDA Compliance Document

Regulatory Action: FDA warning letters or 21 U.S.C. §331 enforcement

Product Seizure: Civil seizure or injunction risk

Civil Penalties: Monetary fines and remediation costs

Operational Delay: Production holds and market withdrawal

Reputational Harm: Loss of customer and partner confidence

Data Integrity Findings: Audit findings under 21 CFR Part 11

eSignature Vendor Pricing Snapshot for FDA Compliance Workflows

Compare typical vendor pricing and key capabilities relevant to regulated document workflows. signNow is listed first in the table to match platform ordering requirements.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes (Premium)	Varies	Varies	Varies	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Practical Tips to Produce Accurate, Audit-Ready Documents

Adopt practices that reduce errors and make inspections straightforward: consistent metadata, robust authentication, and preserved evidence.

Standardize Naming and Versioning

Use a consistent title and version scheme across documents and attachments. Standardization simplifies searches and prevents mismatched evidence during audits.

Capture Full Audit Trails

Record IP addresses, timestamps, and user actions for every signature and edit. Audit trails are central to 21 CFR Part 11 assessments.

Use Strong Signer Authentication

Require multi-factor or identity-proofing for high-risk approvals to demonstrate signer attribution and intent under ESIGN and Part 11.

Preserve Raw Data and Attachments

Include underlying test reports, calibration certificates, and electronic source files to allow inspectors to verify conclusions in the primary document.

How Organizations Use This Document in Practice

Real-world examples show practical application of compliance documents across small and large organizations.

Optica Ventures — COO

The team centralized validation and SOP sign-offs to reduce turnaround time.

Signatures were easier to collect remotely using secure e-signatures.
The result improved customer responsiveness and ensured consistent evidence collection for audits, according to the COO.

Fertility Centers of Illinois — Founder

Clinical and consent records were moved to an electronic workflow to preserve audit trails.

Integration with EMR simplified attachments and metadata.
The founder reported greater confidence in inspection readiness and faster internal approvals.

Frequently Asked Questions About FDA Compliance Documents

Answers to common questions about e-signatures, Part 11, retention, and signer authority when preparing FDA compliance records.

Need help? Contact support

Are electronic signatures acceptable for FDA records?
Yes. Electronic signatures and records are acceptable when they meet applicable controls under 21 CFR Part 11 and federal e-signature law such as the ESIGN Act (15 U.S.C. ch. 96) or relevant state UETA provisions.
What makes an e-signature Part 11 compliant?
Part 11 compliance requires controls such as validated systems, audit trails, unique user IDs, and procedures for signature manifestations and record retention to ensure trustworthiness and reliability.
Who can sign the compliance document?
Authorized individuals with role-based authority should sign; include printed name, job title, and an attestation. For regulatory attestations, senior QA or regulatory officers are commonly designated signatories.
How long must I retain the record?
Retention depends on record type: follow federal minima (e.g., IRS 3 years, HIPAA 6 years) and extend for industry-specific requirements; document retention policy should be explicit.
What authentication strength is recommended?
Use at least two-factor authentication or verified identity proofing for high-risk approvals. Stronger authentication supports signer attribution and reduces the risk of regulatory findings.
How do I correct an error after signing?
Do not alter the signed record. Instead, create a controlled amendment or revision with cross-reference to the original, capture approvals, and preserve both versions and audit trails.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now